Patients with rare cancer mutations in India now have access to a globally approved treatment option. Tanstrive, a targeted cancer therapy from Eli Lilly, has been launched in the country for patients with RET-altered tumors.
A new Roche treatment combination has moved a step closer to the market after the US Food and Drug Administration (FDA) accepted the company’s supplemental Biologics License Application (sBLA).
Aurobindo Pharma has moved a step closer to completing its USD 250 million acquisition of Lannett Company after receiving approval from the US Federal Trade Commission (FTC).
The Centre's latest Dengue Preparedness Review comes at a crucial time as the monsoon season approaches and the risk of mosquito-borne diseases begins to rise across the country.
Specialty drugs are becoming the next big growth driver for Indian pharmaceutical companies as the industry looks beyond traditional generic medicines.
API prices are emerging as a key factor for India's pharmaceutical industry after a recent decline in the cost of active pharmaceutical ingredients (APIs).
The Maharashtra FDA has brought major relief to patients across the state with hospital pharmacy monopoly crackdown. In a fresh directive, the Maharashtra Food and Drug Administration (FDA) has instructed hospitals, doctors, and hospital-linked...
AstraZeneca received approval for Enhertu Expansion in India as the company received regulatory approval for the expanded use of its breast cancer drug Enhertu. The approval from the Central Drugs Standard Control Organisation (CDSCO)...
India may be preparing to offer fresh support to the pharmaceutical industry as it considers extending customs duty exemptions on key petrochemical imports. The proposed duty relief for pharma raw materials comes at a time when drug manufacturers...
India is preparing a major policy initiative aimed at boosting domestic pharmaceutical innovation, with the government working on a new scheme focused on the bulk drug research ecosystem. The proposed initiative is expected to strengthen...